LSE - Delayed Quote GBp
Smith & Nephew plc (SN.L)
At close: October 25 at 5:05 PM GMT+1
Breakdown
TTM
12/31/2023
12/31/2022
12/31/2021
12/31/2020
Operating Cash Flow
733,000.00
608,000.00
468,000.00
877,000.00
935,000.00
Investing Cash Flow
-626,000.00
-448,000.00
-472,000.00
-691,000.00
-606,000.00
Financing Cash Flow
258,000.00
-200,000.00
-926,000.00
-645,000.00
1,164,000.00
End Cash Position
548,000.00
300,000.00
344,000.00
1,285,000.00
1,751,000.00
Capital Expenditure
-432,000.00
-427,000.00
-358,000.00
-408,000.00
-443,000.00
Issuance of Capital Stock
--
--
6,000.00
14,000.00
11,000.00
Issuance of Debt
1,180,000.00
326,000.00
485,000.00
--
1,950,000.00
Repayment of Debt
-551,000.00
-151,000.00
-881,000.00
-267,000.00
-405,000.00
Repurchase of Capital Stock
--
--
-158,000.00
--
-16,000.00
Free Cash Flow
301,000.00
181,000.00
110,000.00
469,000.00
492,000.00
12/31/2020 - 7/1/1988
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
UpgradeRelated Tickers
SOON.SW Sonova Holding AG
312.20
-0.06%
SUN.L Surgical Innovations Group plc
0.5500
0.00%
IHC.L Inspiration Healthcare Group plc
16.50
0.00%
1612.HK VINCENT MED
0.425
-1.16%
MOVE.SW Medacta Group SA
114.20
-2.89%
NCYT.L Novacyt S.A.
56.50
+0.36%
XVIVO.ST Xvivo Perfusion AB (publ)
478.50
+0.74%
ZBH Zimmer Biomet Holdings, Inc.
102.35
-1.59%
ALNOV.PA Novacyt S.A.
0.6780
+2.11%
CREO.L Creo Medical Group PLC
20.00
0.00%